US Patent 7122182 Oncolytic virus therapy
Patent 7122182 was granted and assigned to Wellstat Biologics Corporation on October, 2006 by the United States Patent and Trademark Office.
All edits
Edits on 6 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Jeffrey A. Miller0
Stephen N. Mueller0
William S. Groene0
Edits on 31 Aug, 2023
Golden AI
Edits made to:
Article (+416 characters)
Article
Patent abstract
A method of treating a human subject with cancer is disclosed. A pharmaceutical composition is administered to the subject, the pharmaceutical composition comprising human leukocytes and a replication-competent oncolytic virus in suspension in a physiologically acceptable solution. Alternatively the pharmaceutical composition comprises human leukocytes or platelets infected with an oncolytic virus.
Edits on 22 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 13 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07122182 Oncolytic virus therapy US Patent 7122182 Oncolytic virus therapy
Infobox
Patent Number
071221820
Patent Number
71221820
Edits on 2 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
071221820
Date of Patent
October 17, 2006
0Patent Application Number
101424050
Date Filed
May 9, 2002
0Official Website
Patent Primary Examiner
Edits on 7 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 18 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07122182 Oncolytic virus therapy
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07122182
Date of patent
October 17, 2006
Patent application number
10142405
Date Filed
May 9, 2002
Patent primary examiner
Find more entities like US Patent 7122182 Oncolytic virus therapy
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
